[13] An additional important effect of GLP-1, is inhibition of glucagon secretion at glucose levels above fasting levels
For this reason, I counsel my patients to proceed with caution." All of this is not to say that nutrition can't play a role in boosting GLP-1 production
Available at ID 321012279 | Healthcare Aniloracru | Dreamstime.com
The FDA approved Zepbound for chronic weight management in November 2023, and later expanded it to obstructive sleep apnea in adults with obesity
Weight Loss: In phase III trials, weight loss with the use of exenatide averaged between 0.9 and 2.8 kg over a 30-month time frame, with more weight loss associated when exenatide is added to existing metformin therapy
Es probable que factores genticos y ambientales, como el aumento de los niveles de estrs o una mayor exposicin a alimentos procesados, tambin contribuyan